Jazz Pharmaceuticals (Germany) Top Insiders
J7Z Stock | EUR 118.85 2.00 1.71% |
Jazz Pharmaceuticals employs about 3.2 K people. The company is managed by 10 executives with a total tenure of roughly 21 years, averaging almost 2.0 years of service per executive, having 320.0 employees per reported executive. Examination of Jazz Pharmaceuticals' management performance can provide insight into the company performance.
Bruce Cozadd Chairman Chairman of the Board, CEO |
Daniel Swisher President President COO |
Jazz |
Jazz Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of 0.053 % which means that it generated a profit of $0.053 on every $100 spent on assets. This is way below average. Jazz Pharmaceuticals' management efficiency ratios could be used to measure how well Jazz Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Jazz Pharmaceuticals Workforce Comparison
Jazz Pharmaceuticals plc is rated below average in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 248,511. Jazz Pharmaceuticals claims roughly 3,200 in number of employees contributing just under 2% to stocks in Biotechnology industry.
The company has Profit Margin (PM) of (0.01) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.27 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.27. Jazz Pharmaceuticals plc Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Jazz Pharmaceuticals plc Price Series Summation is a cross summation of Jazz Pharmaceuticals price series and its benchmark/peer.
Jazz Pharmaceuticals Notable Stakeholders
A Jazz Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Jazz Pharmaceuticals often face trade-offs trying to please all of them. Jazz Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Jazz Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Bruce Cozadd | Chairman of the Board, CEO | Profile | |
Daniel Swisher | President COO | Profile | |
Robert MD | Ex RD | Profile | |
Finbar Larkin | VP Operations | Profile | |
George Eliades | Sr Officer | Profile | |
Patricia Carr | VP Officer | Profile | |
Heidi Manna | VP Officer | Profile | |
Neena JD | Ex Officer | Profile | |
Renee Gala | Ex CFO | Profile | |
Andrea Flynn | VP Relations | Profile |
About Jazz Pharmaceuticals Management Performance
The success or failure of an entity such as Jazz Pharmaceuticals plc often depends on how effective the management is. Jazz Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Jazz management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Jazz management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. Jazz Pharmaceuticals plc has licensing and collaboration agreements with ImmunoGen, Inc. Codiak BioSciences, Inc. Pfenex, Inc. and XL-protein GmbH. JAZZ PHARMACEUT operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1460 people.
Jazz Pharmaceuticals Workforce Analysis
Traditionally, organizations such as Jazz Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Jazz Pharmaceuticals within its industry.Jazz Pharmaceuticals Manpower Efficiency
Return on Jazz Pharmaceuticals Manpower
Revenue Per Employee | 966.9K | |
Revenue Per Executive | 309.4M | |
Net Loss Per Employee | 103K | |
Net Loss Per Executive | 33M |
Complementary Tools for Jazz Stock analysis
When running Jazz Pharmaceuticals' price analysis, check to measure Jazz Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jazz Pharmaceuticals is operating at the current time. Most of Jazz Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jazz Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jazz Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jazz Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Stocks Directory Find actively traded stocks across global markets | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Share Portfolio Track or share privately all of your investments from the convenience of any device |